Shah Jatin 4
4 · Karyopharm Therapeutics Inc. · Filed Jul 13, 2021
Insider Transaction Report
Form 4
Shah Jatin
EVP, Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2021-07-12$9.73/sh−665$6,470→ 131,137 total
Footnotes (1)
- [F1]Represents shares withheld to satisfy the reporting person's tax obligation in connection with the vesting of 2,413 restricted stock units on July 11, 2021.